Frontage launches $205m Hong Kong spin-off

By Jonathan Breen
15 May 2019

Chinese drug services provider Frontage Holdings Corp has kicked off bookbuilding for its IPO, vying for proceeds of up to HK$1.60bn ($204.6m).

The firm, being spun-off by China’s Tigermed Group, is looking to float 501.9m primary shares and has put up a 15% greenshoe of 75.3m new shares, according to a term sheet seen by GlobalCapital Asia.

Joint sponsors Bank of America and Goldman Sachs, working alongside global co-ordinators CLSA ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial